Subsequently, the T cell killing assay showed that TM4SF1-AS1 interference significantly weakened the killing effect of activated CD8+ T cells on tumor cells in a T cell concentration-dependent manner (Figures 6C, D). The gene discussed is TM4SF1; the disease is neoplasm.